Abbott Laboratories

Elan Pharmaceuticals

Merck & Co.,Inc


Direct Mail

Abbott Laboratories

This newsletter is designed to educate nephrologists and dialysis nurses about the proper use of Zemplar in patients with end-stage renal disease.

 


© KAPLAN Communications
Not to be reproduced in any way without the expressed permission of KAPLAN Communications

Legal